Cite
HARVARD Citation
Ius, T. et al. (2018). An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. Neuro-oncology. 20 (6), pp. 776-787. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ius, T. et al. (2018). An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. Neuro-oncology. 20 (6), pp. 776-787. [Online].